BioSynesis Inc, spun out of the University of California Merced Lab, focuses on the treatment of infectious diseases using biofilm-specific therapeutics. The company is focused on understanding the molecular mechanisms behind microbial community formation and developing diagnostics and therapeutics that target problematic microbial communities.
